James Brumley

James Brumley

James Brumley is a reformed stock broker and former Director of Research for an options-focused newsletter. He’s now primarily a freelance writer, tapping more than a decade’s worth of broad experience to help investors get more out of the market.

With a background in technical analysis as well as fundamental analysis, James writes with a multifaceted philosophy that combines the importance of company performance with the power of stock-trade timing. His commentary is as apt to focus on a chart as it is earnings, as he believes this dual approach is the only way an investor has a shot at consistently beating the market.

James’ work has appeared at several websites, including Street Authority, Motley Fool, Kapitall and Investopedia. When not writing as a journalist, James works on his book explaining his multipronged approach to investing.

Recent Articles

McDonald’s Corporation: Stop It! China Won’t Reverse the Pain for MCD Stock

McDonald's stock has been tough to own lately, and even a (seemingly) compelling growth goal in China isn't going to change that.

Tesla Motors Inc: Tesla Stock Roars With Model 3 “iPhone Moment”

Owners of Tesla stock have been rewarded for their patience, and guts. They just need to know owning TSLA stock still is a matter of psychological gamesmanship.

Why Allergan plc Ordinary Shares (AGN), Deere & Company (DE) and Micron Technology, Inc. (MU) Are 3 of Today’s Worst Stocks

Allergan plc (AGN), Deere & Company (DE) and Micron Technology (MU) never even had a fighting chance of making gains on Thursday.

10 Biotech Stocks With Big Catalysts Coming This Quarter

Fans of binary trading events should find that these biotech stocks are well poised for big-time volatility over the course of the next several weeks.

SunEdison Inc: TerraForm CEO Resignation Is the Least of SUNE’s Problems

The SunEdison (SUNE) saga continues to drop jaws. But considering all the recent twists and turns, Brian Wuebbels' resignation is the least meaningful.